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I.

Abstract
Increased media coverage on the potential risk of full-contact sports related concussions leading to

Chronic Traumatic Encephalopathy (CTE) has led to a proactive response within the scientific
community. Scientists are in search of a way to diagnose and prevent the spread of this
neurodegenerative disease. In the past, diagnosis of CTE was primarily confirmed by an extensive
autopsy of the brain with a considerable amount of tau protein being a strong indicator of CTE.
Finding new biomarker imaging tools to assess an individual’s brain prior to death is greatly needed. In
the past few years, newly developed tau protein probes have been made available for imaging use in
the area of neurodegenerative diseases. In comparison to prior pathological histology findings present
in CTE diseased brains, the biomarker probes were found to illuminate tau aggregates in the brain with
similar correlating patterns to prior autopsy reports. Biomarkers are available for use in both imaging
and blood serum/ cerebrospinal fluid assays for identifying tau protein. Further research in these areas
is warranted as the definition and clinical symptoms of CTE become clearer.
Keywords: Chronic Traumatic Encephalopathy (CTE), biomarkers, neurodegenerative disease, tau
protein, and traumatic brain injury.
II.

Introduction
Chronic Traumatic Encephalopathy (CTE) is a neurodegenerative disease that is quickly

becoming associated with full-contact sports (McKee et al, 2009). Countless reports of suicide or
premature death are currently being reported in football players, most of which were concluded to have
CTE (New York Times, 2016 adaptation of McKee et al 2012). It has become clear that pre-diagnostic
imaging tools are needed for earlier detection in high risk populations (Gandy et al, 2014). The use of
biomarker imaging tools, blood serum and cerebrospinal fluid assays, with different brain scanning
techniques are mostly ready for use (Barrio et al, Gandy et al, Rubenstein et al, Adam et al, Lipton et
al). Imaging techniques combined with established autopsy findings and patient history will have a
profoundly positive effect in the development of an accurate diagnosis for CTE.
III.
1.

CTE
What is CTE?
Chronic Traumatic Encephalopathy is an advancing neurodegenerative disorder that can be

characterized by an abundance of hyperphosphorylated tau protein, also referred to as p-tau (Stern et
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al, 2013). Tau protein accumulates in specific regions of the brain in the conformation of
neurofibrillary tangles as well as around smaller blood vessels in the brain (McKee et al, 2013). CTE is
believed to be the result of repetitive mild traumatic brain injury (rMTBI); many individuals suffering
from CTE were in an environment that increased the risk for rMTBI to occur (Stern et al, 2013).
Suggested environments primarily include full-contact sports, active war zones, and abusive household
environments (McKee et al, 2013). CTE is identified by autopsy and familial interviews to determine
where an individual lies on the staging scale (McKee et al, 2013). Stages are listed in severity from
least to greatest in an I-IV numbering method; this corresponds with level of tau formation, behavioral/
cognitive changes and observed gross pathological findings (McKee et al, 2013).
a.

Discovery of CTE
In 1928 the precursor to what would be known as CTE was discovered as the repetitive brain
injury Dementia pugilistica (DP) or commonly called “punch-drunk syndrome” (Saing et al, 2012).
Dementia pugilistica was originally identified in professional boxers who were experiencing noticeable
cognitive deficits following repetitive hits to the head during their careers (McKee et al, 2009).
Autopsy reports of one boxer suspected of DP showed that the individual’s brain exhibited
pathologically relevant amounts of neurofibrillary tangles and tau in various conformations (Saing et
al, 2012). Tau protein aggregates were found in the frontal, temporal and parietal lobes and regions
deep to the cerebral cortex of the brain (Saing et al, 2012).
In the past, DP was only associated with boxers which limited the range of sports where DP could
occur (McKee et al, 2009). Recently, American football players have complained of similar cognitive
deficiencies; which upon autopsy have presented with pathologically relevant levels of tau protein in
various regions of the brain (McKee et al, 2009). Brains investigated for CTE have extended the
definition of activity types which are higher in risk for mTBI (McKee et al, 2009). Areas associated
with mTBI risk now include a large variety of full-contact sports, active military experiences, and
cases of abuse (McKee et al, 2009). Presence of hyperphosphorylated tau tangles are now a primary
indicator of CTE in the brains of most deceased athletes with a history of repetitive mTBI (McKee et
al, 2009). It is not difficult to envision how observations of clinical manifestations of DP in
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individuals not associated with boxing could lead to further investigations as to a potential cause
(Saing et al, 2012, McKee et al, 2009).
b.

Neurodegenerative disease
In order to understand the effects of CTE as a neurodegenerative disease it is important to evaluate
possible risks that are associated with mTBI’s. Potential links between other major neurodegenerative
diseases, such as Alzheimer’s, Parkinson’s, frontotemporal dementia and amyotrophic lateral sclerosis,
and mTBI have been evaluated (Gardner et al, 2015). Minimal studies performed and mixed findings
have left the answer to this hypothesis mostly incomplete (Gardner et al, 2015).
Neurodegeneration presented in one study from football player autopsies found an increase in the
players suffering from neurodegenerative diseases at time of death, but were pathologically identified
as major dementias (Gardner et al, 2015). Variability in patient to patient clinical presentation or
autopsy report have made it difficult to determine how cause and effect are correlated.
Despite a lack of clarity between how mTBI may affect the development of CTE, gross anatomical
pathological findings do indicate that neurodegeneration does occur in CTE although severity is
dependent on the progressed stage (McKee et al, 2015). In earlier stages of CTE (Stage I and Stage 2),
gross anatomical changes are minimal if presenting; in particular enlargement of the lateral ventricles
and visualization of the cavum septum pellucidum are observed (McKee et al, 2015). Severe cases of
CTE display more advanced gross pathology indicating atrophy, fenestrations and enlargement of the
ventricles (McKee et al, 2015).
CTE is not based solely on the findings of gross pathology, but rather the accumulation of tau
protein (McKee et al, 2015). Tau observed throughout the four stages can be seen as sparse to
extensive within gray matter of the brain (McKee et al, 2015). It is clear that neurons are subject to tau
formation even in Stage I (McKee et al, 2015). Clinically presented symptoms are a result of the gross
anatomical changes and accumulation of tau in the brain, although confirmation of CTE is still only
possible through autopsy (McKee et al, 2015).

c.

Discovery of Tau in CTE
A study conducted by Corsellis et al examined CTE in the brains of boxers who were of advanced
age prior to death (Corsellis et al, 1973, McKee et al, 2015). Current research has expanded upon prior
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studies where neurofibrillary tau tangles had presented in the brains of boxers suspected of having
Parkinson’s and dementia (Corsellis et al, 1973, McKee et al., 2015). Corsellis et al established a
currently used criteria of relevant pathological findings of CTE in the brain (Corsellis et al, 1973,
McKee et al, 2015). Boxers were still the primary focus of most researchers at the time and it took
slightly over three decades for other full-contact sports to be evaluated. In 2005, a study regarding the
autopsy of a football player with suspected CTE displayed two conformations of tau proteins along
with extensive amyloid plaques (Omalu et al, 2005). In this case the gross pathology of the brain was
not overtly presenting, however it is not uncommon in the autopsied brains of football players that
gross pathology is minimal while tau aggregates are typically more clinically relevant (McKee et al,
2009, Omalu et al, 2005). Inclusion of amyloid plaques in the histological findings of a CTE brain are
a result that is typically indicative of Alzheimer’s Disease (McKee et al, 2009, Omalu et al, 2005).
Which meant that further research to establish a distinguishable difference between CTE and other
neurodegenerative diseases was necessary (McKee et al, 2009, Omalu et al, 2005). Autopsy of a brain
with DP revealed that the frontal, temporal and parietal neocortices contained aggregates of
neurofibrillary tau tangles as well as in regions of the midbrain and cerebellum (Saing et al, 2012).
Similar to the findings in 2005 amyloid plaques were present but in lesser quantities (Saing et al,
2012). In order to distinguish DP further from Alzheimer’s disease histological staining’s of βamyloid plaques and tau tangles were presented for DP, Alzheimer’s disease, Frontotemporal dementia
and one control (Saing et al, 2012). Imaging showed distinct patterns between the three pathologies
and revealed differences in tau types; Alzheimer’s disease associated tau proteins were typically
located closer to amyloid plaques rather than randomly dispersed (Saing et al, 2012). However, in the
CTE brain it was noted that developing tau proteins as well as mature tau proteins were evident which
was used to indicate progression of the disease (Saing et al, 2012). One clarification for the difference
between CTE and Alzheimer’s disease may come from further research on amyloid plaques (Johnson
et al, 2012). Johnson and colleagues noted that prior research indicated that following a traumatic brain
injury amyloid plaques can form acutely (Johnson et al, 2012). Findings also revealed that in patients
with a history of a single mTBI extensive tau formation had developed within 30% of younger brains
(Johnson et al, 2012). In addition, the Alzheimer’s disease APOE genotype allele’s ε3 and ε4 along
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with the other four genotypes are indicated if they are expressed (Omalu et al 2005, Stern et al 2013).
APOE allele ε4 is of significant interest for amyloid plaque development due to a link with
Alzheimer’s related dementia and an association with risk for longer and more severe experiences with
mTBI (Stern et al, 2013). CTE as a tauopathy has distinguishable characteristics that help with
eliminating other neurodegenerative disorders with similar clinical symptoms. (McKee et al, 2015).
d.

Tauopathy
Tauopathies are the result of normal tau protein functions becoming distorted due to
phosphorylation (Williams et al, 2006). In a healthy human body, tau proteins exist as assistants to
microtubule formation in the brain (Williams et al, 2006). Neurodegenerative disease effects tau
protein function, which leads to aggregation of tau protein resulting in an inability to clear these
formations (Williams et al, 2006).
1.

Tau Protein
Normal tau protein is mapped to the MAPT gene located on chromosome 17 (LuckeWold et al, 2014). MAPT codes for six isoforms of tau proteins which is displayed by numbers of
repeats which are edited by the splicing of exons; repeats 3R and 4R are combined towards the Cterminus of the peptide chain (Lucke-Wold et al, 2014). One specific variant of splicing exons,
exon 10 splice known as hTau40, has been correlated with neurodegenerative diseases (LuckeWold et al, 2014). 3R and 4R tau repeats are normally observed in a balanced ratio (Lucke-Wold
et al, 2014). An exon 10 splice dictates an imbalance leading to an overexpression of 3R tau
repeats that are observed in neurodegenerative disorders (Lucke-Wold et al, 2014). CTE tau
repeats are more prevalent in the 4R variation (McKee et al, 2015).
Two types of tau are observed T-tau and P-tau, with T-tau being the Total tau found in
neurons and P-tau being an activated form of tau through phosphorylation (Rubenstein et al,
2015). Excessive phosphorylation of several known sites of serine and threonine in the tau peptide
are regarded as areas where once they are activated will create neurofibrillary tangles (Rubenstein
et al, 2015). Additionally, increased activity of histone deacetylase causes an increase in P-tau
formation which results in the formation of tau aggregates (Cook et al, 2014). Without external aid
from an inhibitor for histone deacetylase, accumulated tau protein cannot be dephosphorylated
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(Cook et al, 2014, Rubenstein et al, 2015). Buildup of tau protein leads to the formation of
neurofibrillary tangles; growth occurs in stages where maturity is identified by acetylated lysine
residue 280 (Lucke-Wold et al, 2014).
Traumatic brain injury can induce axonal and vascular injuries (McKee et al, 2015).
During this time, levels of P-tau and T-tau become significantly detectable in cerebrospinal fluid
and blood serum (Rubenstein et al, 2015). Tau was traced for three to six months in certain
patients with severe traumatic brain injury by Rubenstein et al. Initial levels of P- and T-tau were
higher, however T-tau was able to return to normal range while P-tau remained evident even at the
end of the trial (Rubenstein et al, 2015). Extensive P-tau pathology has been observed in autopsy
based research and is a strong indicator of CTE development (McKee et al, 2015).
e.

Other potentially associated proteins and risks for neurodegenerative disease
1. TDP-43
Transactive response DNA-binding protein 43 (TDP-43) is a microscopically presenting
protein in CTE and other neurodegenerative diseases (McKee et al, 2010, Saing et al, 2012). TARDBP is the gene responsible for encoding TDP-43 on chromosome 1 (McKee et al, 2010). Primary
function of TDP-43 involves acting as a cytoskeleton binding protein and a transcription stabilizer
for mRNA (Costanza et al, 2011). Damage to axonal cytoskeletons during traumatic brain injuries
is proposed to lead to the activation of TDP-43 proteins as a repair response (Costanza et al,
2011). TDP-43 activation is initiated when TDP-43 C-terminus undergoes cleavage resulting in
fragmentation (Lucke-Wold et al, 2014). However, extensive autopsy reports have shown that
Fragmented TDP-43 tends to accumulate rather than displaying proper repair mechanisms, leading
to a similar outcome as tau aggregation resulting in toxicity (McKee et al, 2010, Lucke-Wold et al,
2014, Costanza et al, 2011). TDP-43 aggregation can lead to a blockage of RNA activities as well
as introducing errors into cellular processes which can lead to increased free radical activity
(Lucke-Wold et al, 2014). Tau neurofibrillary tangles with close TDP-43 pathology are
occasionally observed in autopsies (Saing et al, 2012). TDP-43 was also expressed in the brains of
80% of athletes who were also diagnosed with CTE in a particular autopsy report (McKee et al,
2010). How TDP-43 operates with regard to neurodegeneration is not entirely known, however
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further investigation of this protein could lead to better insight regarding tauopathies such as CTE
(McKee et al, 2010).
2.

β-Amyloid
β-amyloid plaques are a clinically relevant identifying protein for a diagnosis of
Alzheimer’s disease, it has also recently been observed in early stages of traumatic brain injury
(Johnson et al, 2012). A potential mechanism for β-amyloid plaque formation involved with
traumatic brain injury is likened to the development of tau; where the process by which preamyloid proteins has been altered due to a traumatic event (Omalu et al, 2005). It is proposed that
CTE and Alzheimer’s disease may enhance the development of one another or follow the same
chemical pathways using similar proteins (Costanza et al, 2011). β-amyloid plaques can
potentially be distinguished between cases of Alzheimer’s disease and traumatic brain injury. In
cases where the plaques presenting lack Alzheimer’s disease specific tangles can act as a potential
eliminating technique for ruling out sporadic Alzheimer’s disease from a list of suggested
pathologies (Omalu et al, 2005). β-amyloid, in traumatic brain injuries, also has a different pattern
of plaque development than most cases of Alzheimer’s disease (Johnson et al, 2012). Plaques
associated with traumatic brain injury exhibit extensive formation throughout the cortex and in
greater amounts (Johnson et al, 2012). Short-lived β-amyloid plaque formation has been observed
in younger individual’s following a traumatic brain injury (Johnson et al, 2012). There are
discrepancies between researchers as to whether β-amyloid is presented in CTE. In cases
regarding traumatic brain injury the presence, absence or association of neurofibrillary tangles and
plaques leaves β-amyloid as a protein to be further investigated (Johnson et al, 2012 Omalu et al,
2005, McKee et al, 2010). The involvement of β-amyloid is not a common hallmark of CTE
although it has presented in autopsy reports (McKee et al, 2010).

3.

α-Synuclein
Parkinson’s disease is histologically hallmarked by the presence of α-Synuclein positive
Lewy bodies (McKee et al, 2013, Omalu et al, 2005, Saing et al, 2012). However, in at least two
autopsy studies, patients with pre-mortem diagnosis of Parkinson’s disease revealed that the brain
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was negative for Lewy body staining (Omalu et al, 2005, Saing et al, 2012). In more extensive
research, findings of Lewy bodies in older patients was not uncommon, and was considered a comorbid finding of CTE with another neurodegenerative disease (McKee et al, 2013). Patients
presenting with Parkinsonian symptoms should receive a full evaluation including any prior mTBI
events in order to properly diagnose this neurodegenerative disease.
Autopsy diagnosis of CTE in brains of athletes has revealed that 37% had some other
neurodegenerative disorder (McKee et al, 2013). One potential theory regarding α-Synuclein
development in brains with CTE is the possibility that a chemical pathway is activated by mTBI
(McKee et al, 2013). A secondary theory is that tau protein might promote abnormal protein
growth as it accumulates, triggering this event (McKee et al, 2013). Traumatic brain injuries have
been suggested to play a role in instigating cases of neurodegeneration and leading to the
formation of abnormal protein development (Omalu et al, 2005, McKee et al, 2013). These
findings support the need for patient history evaluations for mTBI in order to accurately diagnose
neurodegenerative disorders.
f.

Prion theory
As research continues to investigate proteins, such as tau, α-synuclein, or β-amyloid, and the role
that is played in neurodegenerative disorders, a cause and effect relationship has been proposed by the
prion theory of abnormal protein development (Prusiner, 2013). Formation of prions occurs through
conformational changes to normal proteins that begin to self-replicate (Prusiner, 2013). Discovery of
β-amyloid in experiments with Scrapie, a virulent prion infection, lead to the idea that certain proteins
may be prions themselves (Prusiner, 2013).
In general, most cases of neurodegenerative disorders can be determined through genetic testing.
Inheritance of a prion based neurodegenerative disease is actually a smaller risk, of 10-20%, when
compared to the 80% of cases that arise sporadically (Prusiner, 2013). It is presumed that most
neurodegenerative disorders arise from sporadic development (Prusiner, 2013).
The mechanism by which tau protein presumes a prion function in the brain in not completely
understood (Prusiner, 2013). Experimentation with murine and bacterial models have shown that
tauopathies can spread from cell to cell, and that in certain areas of the brain, such as the hippocampus
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and striatum, specific patterns of tau fibrils arise (Prusiner, 2013). When investigating CTE it could be
useful to examine the tau as a prion theory.
2.

Current theory of causation
Repetitive mTBI is the current proposed mechanism for CTE development in the brain
(McKee et al, 2013). Frequent impacts to the brain are believed to activate the formation of
hyperphosphorylated tau which spreads throughout the brain leading to mass neurodegeneration
(McKee et al, 2013). Currently it is difficult to determine whether a single concussive event or
multiple events are needed to actually initiate neurodegenerative disease development (Gardner et
al, 2015). It is also difficult to determine every type of environment, and with what frequency
where multiple concussive events could occur (Gardner et al, 2015).

3.

When does CTE develop?
a. Later stages of life
CTE development does not overtly present itself following an episode of mTBI (Costanza et
al, 2011). Typically, CTE presents as behavioral impairments in the middle aged (Mitsis et al,
2014). The time for CTE to become clinically noticeable is thought to be caused by the changes to
tau protein which may take years to fully display cognitive impairment (McKee et al, 2009). Since
the effects of the damage are ongoing following the event, it is perceived that the longer an
individual lives the more severe the neurodegeneration (McKee et al, 2009).
b.

General age range
CTE clinical symptoms typically begin in a range of 30 to 65 years of age, although
deviations have occurred with presentation in cases of younger and older patients (Mez et al,
2013). Behavioral symptoms usually precede cognitive decline as the stages of CTE progress
(Mez et al, 2013). CTE dementia development does not proceed as quickly as it does with
Alzheimer’s patients, although it is noted that this type of dementia is no less severe (Mez et
al, 2013).

4.

Details of injury and how CTE is caused
a. Concussive vs. sub-concussive injury
Concussions, or mTBI, are the result of high impact forces directed towards the brain or
areas that are connected to brain function where loss of consciousness may or may not occur
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(Costanza et al, 2011). Primary damage sustained by a concussive event is directed towards
brain function (Costanza et al, 2011). A Glasgow Coma Scale is clinically used to determine
an incident of mTBI, and a score of 13-15 is considered a positive for concussion (Gardner et
al, 2015). Sub-concussive events do not elicit clinical symptoms at the acute stage but are still
caused by an impact to the skull (Gardner et al, 2015). CTE is thought to be primarily caused
by repetitive concussive events (Gardner et al, 2015).
b.

Single vs. multiple injuries
CTE is currently linked to repetitive mTBI, however autopsies of individuals with a
history of only one mTBI have some interesting developments (Johnson et al, 2012).
Postmortem studies of brains that experienced an mTBI within a 1-47-year range, prior to
death, were inspected for differences in tau and β-amyloid production compared to normally
aged control brains (Johnson et al, 2012). 34% of individuals under the age of 60, who lacked
age dependent pathology, that had experienced a singular mTBI event displayed
neurofibrillary tau formation (Johnson et al, 2012). Clusters of tau exhibited were not
exhibited in the same patterns as control group findings, and typically mTBI evaluations
displayed more pathological findings than the control group (Johnson et al, 2012). Johnson
and associates determined that patients that survived a single mTBI event would present a
vast tau distribution when compared to normally aging controls (Johnson et al. 2012). Since
tau does not appear rapidly after one traumatic brain injury a neurodegenerative process may
be involved, which was similar to findings with CTE (Johnson et al, 2012).
Multiple traumatic brain injuries are an unavoidable part of many full contact sports and
not limited only to boxing. In the case of a patient who had been a heavy-weight boxer for 13
years who displayed extensive development of tau in the frontal lobe was diagnosed with DP
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Figure 1. Comparison on murine and
human tau blood serum assay levels
following a severe traumatic brain
injury [from left to right: mouse, rat,
and human] (adapted from Rubenstein
et al, 2015).

(Saing et al, 2012). Further investigation of full-contact sports,
such as football, soccer, boxing and martial arts, as well as
military personnel found evidence of CTE when repetitive
trauma had occurred (McKee et al, 2009).

CTE development may have a stronger relationship with repetitive trauma, although
severity of trauma and number of traumatic injury events still remains in question (Gardner et
al, 2015). While pre-diagnostic tools, used for mTBI, will not fully indicate a diagnosis of
CTE it could be helpful for acute diagnosis of injury as a preventative assessment. Real time
diffusion tensor imaging used on active military personnel within a week of injury displayed
slight signal loss in the white matter of the brain, more specifically the superior longitudinal
fasciculus in some participants (Adam et al, 2015). Furthermore, detection of elevated p-tau in
blood serum and cerebrospinal fluid had a positive correlation with mTBI, and could be used
as an identification tool if a traumatic brain injury is suspected (Rubenstein et al, 2015). It
would be beneficial to evaluate mTBI data from acute to chronic stages of injury for a full
understanding of the pathology as it develops.
c.

Force trauma data
1. Murine models
Rodent models have provided significant details on traumatic brain injury when
compared to human data, either from autopsy or from acute clinical findings. Data were
collected from the blood serum and cerebrospinal fluid assays of patients presenting with
severe traumatic brain injury symptoms (Rubenstein et al, 2015). Samples were
compared with rodent brain tissue extracts following impact induced trauma to the brain
(Rubenstein et al, 2015). Rodent model brains experienced an impact speed of 4.5 m/sec
with a 1.5 mm impact depth from a 3.5 mm impactor tip for mice, and a 2.5 mm impact
depth from a 5 mm impactor tip for rats (Rubenstein et al, 2015). Rodent tissue and blood
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samples were assessed at 7 days and 30 days for mice and rats respectively (Rubenstein
et al, 2015). Patients were evaluated for the first 7 days for cerebrospinal fluid changes
and blood serum changes were assessed at one, three and six month intervals following a
severe brain injury (Rubenstein et al, 2015). T-tau is the total tau in the central nervous
system and P-tau is the tau responsible for normal microtubule structuring (Rubenstein et
al, 2015). Figure 1 displays how the tau levels increase in the early stages of the injury
event and remain elevated for a significant period of time following the event
(Rubenstein et al, 2015). Particularly in humans, the T-tau normalized around one month
following the injury, at the six-month marker P-tau levels were still higher than normal
controls (Rubenstein et al, 2015). Cerebrospinal fluid tau was similarly elevated in
humans during the acute stage following trauma; P-tau levels were increasing in all
patients but a patient to patient variability were observed in the elevations of T-tau
(Rubenstein et al, 2015). Changes in cerebrospinal fluid or blood serum may be a way to
evaluate potential chemical mechanisms for CTE formation although research in the area
of acute P-tau levels are further required as the role it has is not fully understood with
regards to pathology (Rubenstein et al, 2015).
Blast waves from explosives in a war setting are also being analyzed for a potential
link between mTBI and CTE (Goldstein et al, 2012). Goldstein and associates compared
the brains of veterans who had been exposed to blast or concussive trauma to mice that
underwent shock tube induced blast wave trauma (Goldstein et al, 2012). Autopsy of
veterans’ brains revealed CTE type damage which included neurofibrillary tau tangles of
the perivascular foci and glial tangles specific to sulcal depths in certain regions of the
frontal, temporal, and parietal cortices (Goldstein et al, 2012). Damage was observed to
Figure 2. Murine model observed
intracranial pressure, head rotation and
kinematics following a reproduction of an
explosive blast wave (Goldstein et al,
2012).

vasculature and neural cells were also noted (Goldstein et al, 2012). The mouse
model was partly used to examine a link between CTE and blast induced
trauma, the other area of concentration was regarding behavioral changes

(Goldstein et al, 2012). A needle hydrophone was inserted into the hippocampus of the
living mouse to monitor pressure changes during the blast exposure, blast shock waves

25

were set to match explosives
in combat at speeds of 450
m/sec penetrating at depths of
11mm in 24 µsec (Goldstein
et al, 2012). Kinematics of the
mouse head where tracked by
following the nose position
during the blast (Goldstein et al, 2012).
When kinematics was compared to

Figure 3. Risk of injury compared to
rotational accelerations in football players
(Rowson et al, 2011).

head positioning there was an observed
increased initial pressure during time of impact with head positioning sharply jerking
forward then back before completion of rotation (Goldstein et al, 2012, see Figure 2).
Neuropathological findings in mice were similar to CTE type trauma exhibited in the
brains of military veterans, which included tau pathology in neural cells with
phosphorylated and pre-tangle tau detected without the presence of matured tau
(Goldstein et al, 2012). Neural cell changes will be discussed briefly in section 5 of this
paper.
2.

Human accelerometer data
Football players are a large at risk group for sports related concussions. Three

college football teams, Brown, Dartmouth and Virginia Tech, gave informed consent to
wear accelerometer tracking devices to measure real time head accelerations for impact
data (Rowson et al, 2011). Football players were affixed with accelerometers in their
helmets, 314 players wore the Head Impact Telemetry (HIT, 6 accelerometers) model and
21 players wore the 6 Degrees of Freedom (6DOF, 12 accelerometers) accelerometers
during practices and game play (Rowson et al, 2011). The accelerations measured head
rotation by remaining contact with the player’s head, and exceeding threshold of a normal
hit was determined to be 14.4 g’s (Rowson et al, 2011). 300,977 head impacts were
tracked with a total of 57 concussions observed (Rowson et al, 2011, see table 1.). HIT
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tracked accelerations were observed with mean values of 1230 + 915 rad/s^2 for subconcussive rotational accelerations and 5022 + 1791 rad/s^2 for concussive rotational
acceleration data (Rowson et al, 2011). 6 Degrees of Freedom accelerometer rotational
accelerations were only available for sub-concussive impacts with mean of 1158 + 972
rad/s^2 (Rowson et al, 2011). There was increased risk of injury associated with larger
rotational accelerations as depicted in Figure 3 (Rowson et al, 2011). It was observed that
concussive outcomes where a result of the physical impact trauma to the brain (Rowson
et al, 2011). The accelerometer data could direct further research in finding new
equipment for athletes and determining high risk positions in game play.
Head impact data

Plane of rotation

Sub-concussive

Concussive

Front/Back of helmet

Primarily sagittal

67.5% , 193,465 hits

47.9% , 33 hits

Side of helmet

Coronal

17.3% , 49,645 hits

12.3% , 7 hits

Top of helmet

Linear

15.2% , 43,526 hits

29.8% , 17 hits

Table 1. Recorded impact data with plane
of rotation compared to positioning of
impact (adapted from data observed by
Rowson et al, 2011).

d. Who it affects and associated risk
Full-contact sports are currently gaining the most attention

with regards to CTE. Many athletes whose brains were diagnosed with CTE began playing
sports between 11 and 19 years of age (McKee et al, 2009). Risks for CTE development due
to environment are significantly higher for athletes and soldiers (Lucke-Wold et al, 2014).
Both groups have been known to have behavioral and psychological changes one year after a
traumatic brain event (Lucke-Wold et al, 2014).
1.

Athletes
Football player’s position, which included offensive linemen, defensive linemen and

linebackers, were associated with significant risk of behavioral changes and cognitive decline
(McKee et al, 2009). Soccer players were studies in attempt to establish a relationship
between neurocognitive decline and the number of times players headed a ball (Lipton et al,
2013). Soccer balls intercepted by “heading” can travel at speeds of 30 m/sec during practice
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drills, or up to 80 m/sec during a game (Lipton et al, 2013). Players that had an average soccer
career of 22.4 years were estimated to have headed a ball 432 times in a year on average
(Lipton et al, 2013). A determined threshold upon evaluation of number of heading events,
and cognitive scores determined that the threshold for changes in cognition was around 1800
headings per year (Lipton et al, 2013). Diffusion tensor imaging data display a temporooccipital white matter with a contrecoup injury type, changes observed in the white matter
where opposite the site of impact (Lipton et al, 2013). In boxers, symptoms of concussive
damage became apparent by observed decrease in speed of movement and fighting skills
during a fight (Costanza et al, 2011). Increased blows to the head and lowered skills leaves a
boxer exposed to further trauma (Costanza et al, 2011). While CTE development is not
limited to football, boxing or soccer traumatic findings from these sports have been applied
when covering potential risks for other full-contact sports.
2.

Military personnel
In active combat, soldiers are at a significantly high risk for blast-exposure
mTBI (Adam et al, 2015, Goldstein et al, 2012). Goldstein and associates force trauma
data, mentioned extensively in the force trauma section, showed that autopsied brains of
veteran’s displayed neuropathological changes indicative of CTE (Goldstein et al, 2012).
Diffusion tensor imaging conducted by Adam et al indicated that following a single
traumatic brain event changes to the white matter of the brain could be observed in acute
stages of injury (Adam et al, 2015). In no certain terms does this information sully the
honor of veteran’s or current military personnel. However, this does indicate a need for
better protective gear for the men and women who serve our country.

3.

Victims of abuse
Cases of abuse may sporadically enter the world of news, but the effects of
abusive trauma are not widely publicized. McKee and associates added a prior case study
of a woman who had suffered severe abuse from her spouse, clinically she was assessed
with dementia where autopsy later revealed findings of neurofibrillary tangles similar to
those found in boxers (McKee et al, 2015). One questionnaire based study evaluated a
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group of school children for traumatic brain injury in comparison to the Conners Parent
Rating Scale which would indicate problem children (Dams-O’Connor et al, 2014). 44%
of children reported a traumatic brain event while 10% where positive for chronic
traumatic brain injury (Dams-O’Connor et al, 2014). 79% of the chronic cases exhibited a
positive Conners rating and 80% of the chronic cases found a decline in cognitive
function (Dams-O’Conner et al, 2014). Juvenile delinquents in the juvenile justice
department of El Paso were among another group to take the traumatic brain injury
questionnaire (Dams-O’Connor et al, 2014). 271 juveniles were assessed for traumatic
brain injury and 76% of these individuals admitted to experiencing one traumatic brain
injury (Dams-O’Connor et al, 2014). It was noted behavioral changes and an increased
level of delinquency are associated with an experience of a traumatic brain injury (DamsO’Connor et al, 2014). It should be further noted that abusive environments are a primary
risk to the victim although in some cases escape from trauma may be unachievable.
5.

Other potential contributory factors to CTE development
a. Age
A diagnosis of CTE in the aged has proven difficult due to the fact that risks for
neurodegenerative diseases tends to increase over time (Maroon et al, 2015). Age related risks
may explain the compounded findings of CTE with signs of other neurodegenerative
disorders that add to the difficulty of a true CTE diagnosis (Maroon et al, 2015). Data
regarding CTE development as a whole process is also limited to stages of development
(Maroon et al, 2015). Brain injuries in the aged are regarded as severe with acute stages of
injury displaying signs of cognitive impairment and neurotrauma (Turner et al, 2015). Trauma
to the brains of younger individuals is subject to extreme debate (Mez et al, 2013).
Researchers speculate that brain plasticity should elicit a better recovery time, while others
propose that immature brains are at risk of improper development following a concussion
(Mez et al, 2013). What is clear is that the lack of data regarding CTE in an extensive array
of ages is needed in order to understand full progression of the disease (Turner et al, 2015).
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b.

Sex
In general, a large amount of CTE reported data involves male participants, however data
regarding concussion recovery and potential CTE development is needed (Mez et al, 2013).
Female athletes tend to experience stronger and more frequent concussion rates when
compared to males (Mez et al, 2013). Estrogen has been known to display protective
mechanisms for immune function when in higher circulating concentrations (i.e. pregnancy
levels of hormone) (Kovacs et al, 2002). The exact relationship between estrogen and immune
response is not fully understood (Kovacs et al, 2002). Female mice displayed a 10-fold
increase in concentration of estrogen when compared to males in response to burn trauma
(Kovacs et al, 2002). A delay in the onset of immune sensitivity was also expressed in female
mice, compared to the rapid onset of immune function by males, which was proposed to
imply a cytokine neutralizing survival technique (Kovacs et al, 2002).
Cortical contusions, as a result of mTBI, measured in female rats were of smaller volume
than their male and ovariectomized female counterparts (Bramlett et al, 2001). The difference
in contusion volume was attributed to endogenous hormonal protection provided in normal
female rats (Bramlett et al, 2001). Estrogen and progesterone were considered the most
probable reasons for cerebral protection (Bramlett et al, 2001).

6.

Parts of the brain affected by CTE
a. Multiple gross anatomical regions of the brain
Omalu et al presented the first case report regarding the potential substrate responsible
for CTE which resulted in a finding of tau protein with β-amyloid plaques in the brain of a
deceased NFL player (Omalu et al, 2005). In terms of gross pathological findings staining revealed
little to no atrophy which could not be explained by aging (Omalu et al, 2005). Specialized
staining procedures revealed abnormal protein development in the frontal, temporal, parietal,
occipital, cingulate cortex and the insula (Omalu et al, 2005). It is possible that the progression of
CTE in this individual was at a less severe stage of development due to further findings of affected
structures by McKee and associates (McKee et al, 2013). In a larger study, the extent of gross
pathological findings was determined by a categorizing of stages of development with an I-IV
method (McKee et al, 2013). Brains used for this autopsy ranged from ages 14-98 years old
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Table 2. Summary of CTE stages of development attributed to autopsy research by McKee et al (2013).
(Table adapted by Sundman et al, 2015).
(McKee et al, 2013). The stages build upon one another so that as the stages increase in severity
the number of affected locations tend to increase (McKee et al, 2013).
Neurons require oxygen via endless blood flow from nearby capillary beds in order to
create energy required for cellular respiration (Doshi et al, 2015). When mTBI occurs there is a
chance of vascular damage leading to a change in blood flow which could cause regional oxygen
level variations (Doshi et al, 2015). Whether the brain is oxygen starved or in excessive amounts
may depend on the time at which the patient undergoes scanning and the severity of the
concussive event (Doshi et al, 2015). Changes in oxygenation of brain tissue may explain why tau
has been discovered around certain regions of the brain (Doshi et al, 2015, McKee et al, 2015).
Evidence from this report displays the migratory nature of the disease and tau formation. The list of
noticeable brain structures effected is substantial. Information from this research has led to an update of the criteria
for CTE diagnosis, which would cover a larger array of repetitive mTBI patient types (McKee et al, 2013, Sundman
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et al, 2015, see Table 2). In particular, this expands the definition to
include hyperphosphorylated tau development on the microscopic
level along with gross pathological changes (McKee et al, 2013, see
Figure 4).
b.

Neural cells
Injuries to the brain that consist of a rapid acceleration-

deceleration, and rotational forces creates severe strain on neurons,
glial cells, and blood vessels (McKee et al, 2015). Somatic changes
in murine neural cells, in the acute stages of a traumatic event,
indicate cell death around the impact location, loss of somatic
dendrites and a decrease in regional synapses (Goa et al, 2011). In an
experiment with blast-induced trauma to mice “dark neurons” were
observed near damaged capillaries (Goldstein et al, 2012). Dark
staining of the nucleus was a positive indicator of necrotic or
apoptotic mechanisms within the cell, which featured a condensed
nucleus and an electron-dense cytoplasm (Goldstein et al, 2012).
The most damage was observed in the stretching of axons and
blood vessels housed within the perivascular regions and deep in the
cerebral sulci near the point of impact (McKee et al, 2015). These
injuries lead to axonal sheering cutting off the connection between
axon and the soma and a disruption of the blood-brain-barrier which
elicits a repair response (Lucke-Wold et al, 2014). Once the axon is
cut from the soma the cell will die cutting off links to surrounding
cells (Lucke-Wold et al, 2014).
Astrocytes take on the role of notifying the surrounding neurons
Figure 4. The stages of tau development in CTE.
Hyperphosphorylated tau is indicated by areas with
brown staining patterns observed. (McKee et al,
2013).

of pain, activating glial fibrillary acidic protein for microfilament
production and activating the release of self-renewing neurospheres
(Lucke-Wold et al, 2014). The astrocytes spread out in the white
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matter of the brain, particularly in the corpus callosum, motor and somatosensory cortices
(Lucke-Wold et al, 2014). Astrocyte activation may also stem from microglia-mediated
crosstalk as immune cells release cytokines in response to mTBI (Lucke-Wold et al, 2014).
Uptake of the released cytokines initiates the release of reactive oxygen species from the
astrocyte which propagates excitotoxicity (Lucke-Wold et al, 2014).
Activation of microglia leads to a stimulation of neuroinflammation as it continues to
expand (Lucke-Wold et al, 2014). If the injury is a singular event microglial activation is
thought to be a protective mechanism, however neurodegeneration will ensue if multiple
injuries occur and could contribute to the formation of glial tangles which will attribute to
further long term damage (Lucke-Wold et al, 2014). Microglial release of inflammatory
cytokines can also contribute to tissue damage if triggered to do so (Lucke-Wold et al, 2014).
c.

Behavioral and cognitive changes
The spectrum of behavioral changes observed in athletes may be dependent upon type of
traumatic contact in sport (McKee et al, 2009). Clinically presenting symptoms of CTE could
involve any of the symptoms seen in Table 2. (McKee et al, 2009, Sundman et al, 2015). CTE
behavioral presentations in boxers is often hallmarked by increased apathy when compared to
other CTE-sport related behavioral changes (Gandy et al, 2014). Military personnel and other
full-contact athlete types tend to exhibit aggressive or depressive behaviors, which could be
attributed to illegal substance abuse (Gandy et al, 2014). Changes in behavior and executive
function depend on where in the brain CTE damage was found (McKee et al, 2013, Sundman
et al, 2015, Table 2). A recent proposal to explain the reason why some individuals, with a
known CTE diagnosis, are more prone to either cognitive decline or behavioral changes was
that there could be two different phenotypic expressions in developing CTE (Stern et al,
2013). The behavior/mood group was characterized by aggression or depression found at
younger ages (Stern et al, 2013). Cognitive decline developed at a later period (Stern et al,
2013). The cognition group primarily exhibited signs of impaired episodic memory with
strong indications of developing dementia (Stern et al, 2013). Table 3 further displays
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differences between the two phenotypes observed by family
member recounts of patient history (Stern et al, 2013).
d.

Potential changes in motor function
CTE progression is proposed to have a motor decline

element in later stages of disease development (McKee et al,
2009). Typically, this follows behavioral and cognitive
impairment and can clinically appear as symptoms of
Parkinson’s disease (McKee et al, 2009). CTE changes to
motor function are associated with length of athletic career
and number of sustained brain injuries (McKee et al, 2009).
Changes observed are broad, including areas of hearing,
gustation, optical, speech and ocular changes having
appeared in late stages of the disease (McKee et al, 2009).
Impairment to the brain has been associated with tau linked
neurodegeneration in the brain which has shown to be
extensive at later stages (Gandy et al, 2014, McKee et al,
2009). Chronic traumatic encephalopathy- motor neuron
disease (CTE-MND) is a comorbid disease diagnosed when
CTE and amyotrophic lateral sclerosis is presented in the
Table 3. Differences in initial clinical
observation of athletes with a postmortem
diagnosis of CTE separated into two
clinically presented phenotypes (Stern et
al, 2013).

spinal cord (McKee et al, 2013). CTE-MND do not clinically
present at the same time, rather CTE cognitive and behavioral
changes are observed first with MND motor changes soon to

follow (McKee et al, 2013). Eight brains in the McKee et al autopsy study were found to have
CTE-MND; clinical assessment for living individuals should include cerebrospinal fluid
biomarkers to determine if a diagnosis of CTE-MND is present (McKee et al, 2013, Gandy et
al, 2014).
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7.

Factors that could interfere with diagnosing CTE
It is not uncommon for patients hospitalized due to concussion to receive IV fluids or
opiates (Doshi et al, 2015). In some cases, patients presenting with a concussion may receive a
battery of tests for drugs, alcohol and prescriptions as well as painkillers or IV fluids (Doshi et al,
2015). In a study conducted by Doshi et al at the acute stage of concussive events displayed that
six individuals tested positive for alcohol, cannabinoids, opiates and benzodiazepines (Doshi et al,
2015). Four patients received IV fluid; either normal saline or potassium chloride (Doshi et al,
2015). IV fluid administration could lead to altered data when evaluating cerebral blood flow
following a concussive event (Doshi et al, 2015). When a diagnosis of CTE is to be determined
clinically it is suggested to get a complete patient history that may include any illicit drug use,
alcoholism or anabolic steroid use as there could be a link between substance abuse and P-tau
formation in the brain (McKee et al, 2015). Substance abuse has been shown to increase the
chance of neurodegenerative disease development which may include tau formation (Maroon et al,
2015). Specifically, in cases of opiate abusers, P-tau aggregates with enhanced conformations
have been observed (McKee et al, 2015, Maroon et al, 2015).

8.

Assessment tools for CTE development
a. Past and current confirmed CTE diagnosis
In the initial stages of CTE discovery, when it was labeled as Dementia
Pugilistica, neuropathological aberrant protein formation and gross pathological features
were determined by autopsy report (McKee et al, 2009, Saing et al, 2012). In fact,
autopsy based findings observed by Omalu et al diversified another potential sport that
could be involved with CTE formation by including American football (McKee et al,
2009, Omalu et al, 2005). In current research extensive autopsy, histological and patient
pre-mortem family/clinical history are included for determining a CTE diagnosis (McKee
et al, 2009, Omalu et al, 2005, Saing et al, 2012). Unfortunately, a confirmed diagnosis is
only confirmed by autopsy reported findings (McKee et al, 2009).
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b.

Recent contributions to current practices in development
1. Blood serum and cerebrospinal fluid assays
In a recent study evaluating levels of p- and t-tau, following a severe traumatic
brain injury, an ultrasensitive immunoassay was used to assess tau in blood serum
and cerebrospinal fluid (Rubenstein et al, 2015). Anti-tau monoclonal antibodies and
epitopes were used for isolation purposes in assessing levels of tau in the collected
fluids (Rubenstein et al, 2015). Enhanced immunoassay multi-arrayed fiberoptics
(EIMAF) was used directly along with rolling circle amplification EIMAF for
detection of tau in serial dilutions of fluids for increased sensitivity (Rubenstein et al,
2015). Figure 1, exhibited previously in this research, displays the elevated tau
findings from this immunoassay (Rubenstein et al, 2015).
2.

PET scanning and biomarkers
a. Biomarkers
PET imaging has come to include seven types of biomarkers available for
experimental use (table 4) (Dani et al, 2016). Biomarker imaging ligands are
being used to illuminate tau protein in the brain. One major benefit of the
biomarkers is the ability to find tau protein formation in individuals prior to
death (Gandy et al, 2014). Biomarker use applies to many neurodegenerative
diseases where it better serves as both a diagnostic and a differential imaging
tool. A good example of biomarker use comes from the studies of Dickstein et al
and Mitsis et al. These two groups used Florbetapir, as a biomarker for AD
amyloid plaques, and [18F] T807 as the biomarker for CTE related tau protein
(Dickstein et al, 2016, Mitsis et al, 2014). [18F] T807 was used specifically due
to its preferential binding of tau protein as opposed to β-amyloid protein
(Dickstein et al, 2016). Data regarding binding affinity shows a secondary
benefit of biomarkers due to the observed protein binding preferences which
further distinguishes between diseases. Radiopharmaceuticals have shown the
ability to bind tau with such high specificity that it can target specific types of
aberrant tau (Zimmer et al, 2014). Certain quinolone biomarkers such as THK-
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PET Biomarkers
Chemical derivative

Biomarker

High affinity

Low affinity

5117 exhibit increased binding

Naphthalene

[18 F] FDDNP

Tau
β-amyloid

TDP-43
aggregates
α-synuclein

affinity for abnormal tau aggregates
(Zimmer et al, 2014). Biomarkers

Quinolone

[18 F] THK-523

Tau

β-amyloid

also exhibit the ability to bind

Quinolone

[18 F] THK-5117

Tau

β-amyloid

specific sites located with the

Quinolone

[18 F] THK-5351

Tau

Non β-sheet

aberrant tau (Zimmer et al, 2014).

conformations

b.
person

PET scanning in a living

Benzimidazole Pyrimidines

[18 F] T807

Tau

β-amyloid

Benzimidizole Pyrimidines

[18 F] T808

Tau

β-amyloid

Benzothiazole

[11 C] PBB3

Tau

Non β-sheet

can display uptake and spatial

conformations

localization of low concentrations of

Positron emission tomography

radioactive biomarkers that have
Table 4. PET biomarkers suggested for identifying tau protein in the brain
(adapted from Dani et al, 2016, Liu et al, 2007 and Zimmer et al, 2014).

been intravenously administered
(Gandy et al, 2014). [F-18] FDDNP,

2-(1- {6- [(2-[18F] fluoroethyl) (methyl) amino]-2-naphthyl} ethylidene)
malononitrile, was developed as a PET biomarker for assessing neurodegenerative
disease progression in a living person (Liu et al, 2007). Biomarkers exhibit high
binding affinity for specific proteins involved in neurodegenerative diseases (Liu et
al, 2007). Barrio and associates performed PET scanning on retired American
football players who were deemed at risk of CTE development due to multiple
concussive and sub-concussive events (Barrio et al, 2015). [F-18] FDDNP was used
to image fibrillar neuroaggregates in the football players compared with a
cognitively normal group and patients exhibiting Alzheimer’s disease (Barrio et al,
2015). Topographical pattern formation determined in prior autopsy studies were
also used when assessing PET scan patterns of fibrillar proteins (Barrio et al, 2015).
The four stages of CTE development established by McKee et al (table 2) were used
as parameters for identification of patterns for each stage of CTE development
(Barrio et al, 2015). Patterns of tau in the brains of CTE suspected football players
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exhibited similar results to prior
determined autopsy results, and had a
distinct difference from Alzheimer’s
patients (Barrio et al, 2015).
Distribution volume ratios were used to
assess differences in signal strength to
indicate patterns which were used to
establish stages of potential CTE
development, and further distinguish
suspected CTE from Alzheimer’s disease
in living participants (Figure 5) (Barrio
et al, 2015). Suspected cases of CTE in a
living person should be assessed by
a PET scan since biomarker
sensitivity is capable of identifying
specific molecules (Gandy et al,
2014).
3.

Figure 5. [F-18] FDDNP PET signal patterns for stages
T1-T4, core regions were determined to be the amygdala
and dorsal midbrain which consistently presented in the
football player group indicated by stronger signals
(Barrio et al, 2015). Overlap between brain locations
found in Alzheimer’s disease (AD) group and mTBI
group were distinguished by a stronger signal in the
mTBI grouping (Barrio et al, 2015).

DTI scanning
Diffusion tensor imaging (DTI) is a type of MRI that uses protons which are
specifically found in water molecules as a noninvasive probe of neuroanatomy (Mori
et al, 2006). DTI uses water flow along axons to determine anisotropic events, where
water movement is parallel to axon fibers, and isotropic events where water moves
perpendicular to axon fibers indicative of obstacles (Mori et al, 2006). One major
benefit of DTI is fact that it can be performed in just a few minutes (Mori et al,
2006).
Studies involving use of DTI imaging for changes in neuroanatomy were
constructed by Adam et al and Lipton et al. The soccer maneuver known as heading
was found to display contrecoup injury with increased incidence of heading (Lipton
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et al., 2013). DTI results identified three regions in the temporooccipital white matter that had significantly low fractional
anisotropy (FA) results (Lipton et al, 2013). Increased heading
exposure was potentially correlated with lower FA results, however
patient history did not explain these findings (Lipton et al, 2013). A
study conducted in recently concussed military personnel using DTI
imaging revealed slight changes in the FA results of the white matter
of the brain as displayed in Figure 6 (Adam et al, 2015). Adam and
associates reported that although the study was smaller, imaging
resolution being substantially below quality and control participants
were not perfectly matched, DTI was still able to relay some
Figure 6. Part A displays the slight shift in
fractional anisotropy values between mTBI
groups of military personnel who experienced a
blast-induced concussive event compared to
normal uninjured controls (Adam et al, 2015).
Part B displays DTI fractional anisotropy
differences between a participant in the mTBI
group and normal control with specific attention
to the superior longitudinal fasciculus (Adam et
al, 2015).

information regarding post concussive injury which could be
beneficial for patient evaluations (Adam et al, 2015). Both studies
displayed the benefit of having a noninvasive imaging procedure to
examine patients (Adam et al, 2015, Lipton et al, 2013).
9.

How imaging techniques will provide a more accurate

diagnosis of CTE

Investigations of CTE development with compounded data from autopsy report and an
imaging source, such as the one used in the Barrio et al study, are significantly useful for
diagnosing the brain prior to death (Barrio et al, 2015). In epidemiological studies of CTE
incidence evaluations of past autopsy report, imaging devices and clinical history have furthered
the discussion regarding indirect risks associated with CTE development along with the known
causation of repetitive mTBI (Mez et al, 2013). Research on biomarkers and imaging techniques
furthers the discussion of CTE development and induces studies to continue on for this particular
neurodegenerative disorder (Mez et al, 2013). Studies regarding CTE are suggested to involve a
variety of scientific fields and resources in order to continue the discovery of new information
pertaining to the disease (Gandy et al, 2014).
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10. Potential treatments for CTE
a. Lithium based treatment for mTBI
Lithium based treatment could be used as a preventative medicine against CTE
development if administered to patients that present with a concussion (Leeds et al, 2014).
Neuronal loss due to mTBI can spread out from the site of injury which is linked to glycogen
synthase kinase-3 (GSK-3) activity (Leeds et al, 2014). GSK-3 exists in two different isoforms
alpha and beta, however the beta isoform has been more strongly attributed to promoting apoptotic
pathways following mTBI (Leeds et al, 2014). GSK-3 is one of the proteins responsible for normal
tau phosphorylation at serine and threonine locations within a tau polypeptide (Lucke-Wold et al,
2014). Improper stimulation of this kinase protein leads to the hyperphosphorylation of tau and
activation of apoptosis (Lucke-Wold et al, 2014). Lithium has the potential to inhibit the negative
effects of GSK-3 through direct and indirect mechanisms (Jope, 2003, Leeds et al, 2014). Lithium
acting directly on GSK-3 protein competitively inhibits magnesium ions from binding, which
terminates further phosphorylation pathways (Jope, 2003, Leeds et al, 2014). Indirect inhibition of
GSK-3 is thought to occur through phosphorylation of serine 9 (GSK-3β) or serine 21 (GSK-3α)
by activated phosphatase proteins; the exact process by which this occurs is not fully understood
(Leeds et al, 2014, Feng et al, 2014, Jope, 2003). Feng and associates showed that the
neuroprotective qualities of lithium could be enhanced by compounding with valproate, another
type of mood disorder drug with similar qualities to lithium (Feng et al, 2014, Leeds et al, 2014).
Individuals hospitalized for mTBI could benefit acutely from the effects of lithium based
treatments. CTE could be deterred by inhibiting hyperphosphorylated tau development in the
initial stages of injury.
IV.

Past and current opinions on CTE in sports
1. Societal views
a. Acceptance of facts
Extensive coverage of CTE in the media is thought to be the reason why many
athletes, especially football players, are volunteering for studies regarding disease related
changes (Seichepine et al, 2013). The NFL’s response to increased concussion awareness
has resulted in frequent policy changes, however the reasoning behind the rule changes
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could be to avoid litigation (Anderson et al, 2012). Current concussion guidelines should
prevent players from returning to play if a concussion is suspected (Anderson et al,
2012). Michael Strahan a retired football player, related that athletes should be protected
from themselves when it comes to handling players with concussions (FOX Sports,
2009). Jimmy Johnson, a former NFL coach, shared that if a player had a concussion the
player would not be returned to game play without approval by the NFL team medical
staff (FOX Sports, 2009). The sentiments of Johnson and Strahan gives a small indication
that the attitude towards protecting concussed individuals from further play are
encouraged (FOX Sports, 2009).
The NFL has begun working together with NIH researchers by acting as
financial support to further conduct research in the areas of mTBI and CTE (Gandy et al,
2014). Jeff Miller, the top health and safety officer of the NFL, positively affirmed that
CTE is a real risk for football players during a discussion with the U.S. House of
Representatives Committee on Energy and Commerce which featured concussions as a
topic (Fainaru, ESPN article, 2016). Wider media coverage about the potential link
between multiple concussions and CTE has triggered a discussion in the athletic
community. Information gathered from research on CTE can further help coaches,
players and the sports community to truly understand the dangers of concussions.
b.

Denial of facts
Despite the evidence of a potential link between CTE and multiple concussions
the formulation of a plan to help protect players has been underwhelming. It appears that
major sports corporations, involved with rule decision making and player protection, are
less inclined to make changes that would affect their profitability (Goldberg, 2013).
Furthermore, past actions of NFL coaches and side-line medical staff has led to a lack of
response to player care to prevent a player from returning to play with a concussion
(Goldberg, 2013). Prior to the admission of CTE related risk by Miller, the NFL strongly
denied any evidence of potential dangers to players posed by game play (Gandy et al,
2014, Fainaru, 2016). Football players, like Ray Lewis and Terry Bradshaw, have
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extremely negative views on how the NFL views the athletes (Fox Sports, 2009, Charlie
Rose, 2015). Terry Bradshaw made it clear that the reasoning why there has been a lack
of response from the NFL has been due to greed and a complete lack of care (Fox Sports,
2009). Ray Lewis expressed that the NFL does not care about players and that that is the
reason why athletes are the only individuals that are penalized (Charlie Rose, 2015).
Lewis further puts the NFL in a poor light by advocating that concussions are not a
danger, but merely a part of the job (Charlie Rose, 2015).
One potential area for investigation in the problem with concussed players
remaining in play would be with the team specific medical staff and interactions with
coaches. In an anonymous web survey submitted to NCAA athletic trainers and clinicians
for college level sports, over half of the participants responded positively to experiencing
pressures from coaches (64.4%) and athletes (53.7%) to return concussed players earlier
than advised to game play (Kroshus et al, 2015). Sex and years of experience also played
a role in how coaches and athletes treated clinical staff; females and clinicians with fewer
years of experience were more likely to be pressured by coaches or athletes (Kroshus et
al, 2015). One primary reason suggested for pressure on clinicians and trainers to return
injured athletes to play was based on which NCAA division category the personnel
provided care (Kroshus et al, 2015). While the number of participants may have been
lower than expected the results show a benefit to collecting data anonymously (Kroshus
et al, 2015).
Athletes are another group of interest when evaluating the problems regarding
concussion awareness and reporting concussive injuries. In a recent telephone survey
472 athletes, of various sports and levels of sport, were asked about previous concussive
history in comparison to an older definition and an updated definition of concussion
(Robbins et al, 2014). Sports included in this study were diverse including both fullcontact sports and non-contact sports which broadened the definition of athletic types
where concussions could be a risk (Robbins et al, 2014). Participants voluntarily
responding to the study showed an increase in the number of perceived injuries after
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being told the updated definition of what is considered a concussion (Robbins et al,
2014). Current and retired athletes responding to the study seemed to be more aware of
the outdated definition of a concussion, however this was attributed to the time at which
the athlete performed the sport (Robbins et al, 2014). Robbins et al proposed that
clinicians should inform athletes earlier in the season as to what counts as a concussion
(Robbins et al, 2014). Negative involvement of clinicians in concussive care and an
apparent lack of information on concussions from this group shows a further demand for
investigation on the level of involvement clinicians have with athletes (Kroshus et al,
2015, Robbins et al, 2015. It is clear that once given a current definition of a concussion
that athletes become better educated, which could lead to more accurate reporting of
concussive events (Robbins et al, 2014).

a.

2. Athlete complaints
Litigation
Amidst the awareness of CTE and its link to repetitive mTBI athletes that participated in
full-contact sports have sought compensation via legal action. Case history regarding these
claims are limited due to the fact that many cases are quickly ushered into settlement
agreements. In a particular case against the NFL, retired football players were required to
enter into settlement agreements due to rules created by the NFL which were presented at the
time of contract signing (In re National Football League Players, 2015). Claims brought
against the NFL were related to a lack of information regarding concussions and the potential
for further harm stemming from these injuries (In re National Football League Players, 2015).
Retired football players further added that the promotion of aggressive behaviors by the NFL
also lead to player endangerment (In re National Football League Players, 2015). Negotiations
between the two parties were extensive and prior to the judicial intervention the NFL had
created another suspiciously worded agreement (In re National Football League Players,
2015). In regards to CTE, a diagnosis is only confirmable by autopsy report and therefore
money awarded for developing the disease is only granted after an athlete’s death; this is in
the sum of $4 million dollars (In re National Football League Players, 2015). Proof of
negligence by the NFL, as an employer, is evident and the fact that 20,000 NFL athletes were
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involved in the settlement displays that athletes feel mislead and mistreated by the individuals
in charge of player safety and guideline regulations (In re National Football League Players,
2015).
Six retired National Hockey League (NHL) players entered into litigation with the NHL
over the same claims as the retired NFL players (In re National Football League Players,
2015, In re National Hockey League Players, 2016). One, albeit morbid, benefit that is
helping hockey players display negligent actions of the NHL was the decision to require
players to wear helmets which occurred in the late 70’s (In re National Hockey League
Players, 2016). While the NHL argues that players should have understood risks of injury at
the time of contract signing, and that this does not require the NHL to have significant
involvement in player protection (In re National Hockey League Players, 2016). Retired
players also cited that in the late 90’s protective shielding around the hockey rink was
required to be more flexible to prevent injuries to athletes (In re National Hockey League
Players, 2016). Promotion of violence in the sport was also cited against the NHL, however
the NHL did not agree with this claim and argued that rules created should be examined to
determine if the NHL has the ability to enforce them (In re National Hockey League Players,
2016).
Retired athletes from two different full-contact sports presented similar claims against
former employers on their own behalf as well as, on the behalf of all other players (In re
National Football League Players, 2015, In re National Hockey League Players, 2016).
Retired NHL players admitted that experiencing hits from other players was within the scope
of employment, however long-term effects to the brain did not fit into perceived risks upon
contract signing (In re National Hockey League Players, 2016). In both cases retired athletes
felt mislead and poorly educated about potential risks and that current information regarding
neurodegenerative diseases, like CTE, have prompted the request to enter into litigation (In re
National Football League Players, 2015, In re National Hockey League Players, 2016).
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b.

Quality of life with CTE
Jim McMahon, a former NFL player, along with other NFL retirees discussed
the suicide of Dave Duerson in an interview on ESPN (Youtube, CTE, 2016). The NFL
retirees went on to discuss Duerson’s complaints regarding memory problems, headaches
and feelings of aggression (Youtube, CTE, 2016). McMahon sought medical treatment
after experiencing similar cognitive and emotional problems to Duerson (Youtube, CTE,
2016). Jim McMahon was diagnosed with early-onset dementia which stemmed from a
severe decrease in cerebrospinal fluid flow just below the skull (Youtube, CTE, 2016).
Damage to McMahon’s brain is irreversible but early diagnosis has helped McMahon
develop a regiment to deal with memory loss and pain (Youtube, CTE, 2016). Dave
Duerson’s suicide has been taken very seriously by former players of the NFL and many
expressed deep concerns of developing similar issues (Youtube, CTE, 2016).
Former mixed martial arts athlete Gary Goodridge spoke bluntly about what life
is like with neurodegenerative dementia (Youtube, AXS TV Fights, 2016). Goodridge
made similar complaints to other athletes suffering from CTE type symptoms citing
aggression, memory problems, suicidal thoughts and occasional slurred speech (Youtube,
AXS TV Fights, 2016). Early detection and medicinal intervention is what Goodridge
attributes to aiding everyday life (Youtube, AXS TV Fights, 2016). In a video diary of
Goodridge’s daily activities there were frequent complaints of feeling tired,
argumentative and confusion or forgetfulness (Youtube, AXS TV Fights, 2016). In terms
of a long-term prognosis for Goodridge’s mental state, it is expected that cognitive
decline will continue until death (Youtube, AXS TV Fights, 2016).
Research by Omalu et al and McKee et al presented findings of cognitive and
behavioral changes in athletes suspected of having CTE. In a case presented by Dr.
Bennet Omalu et al the first indication of CTE as a result of football related concussions
were displayed (Omalu et al, 2005). Patient history collected from surviving relatives
showed the NFL player experienced changes in behaviors, issues with executive function
and Parkinson’s type symptoms, although it was noted that no Lewy bodies were present
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at time of autopsy (Omalu et al, 2005). McKee and associates highlighted specific cases
of players, one football player and two boxers (McKee et al, 2009). In one case an
American football player experienced a decrease in memory, and aggression which
continued to worsen until death from an accidental gunshot wound (McKee et el, 2009).
Patient histories for the two boxers revealed behavioral changes, especially extremely
aggressive behavior which often lead to abusive actions against family members, and
severe memory loss (McKee et al, 2009). Findings presented by researchers, retired
athletes and surviving family members depict a poorer quality of life as an expected
outcome for athletes that have suffered multiple blows to the head.
V.
1.

Potential solutions for prevention of CTE
Updating equipment (currently in testing stage)
a. Shock absorbing helmets (VICIS Zero 1 helmet)
A group of engineers and neurosurgeons in Washington state began working
together to create VICIS which implements protective technology into helmets for
football (VICIS Co., 2016). VICIS associates have engineered a helmet that is comprised
of two layers with compressing filaments that respond to external force by twisting and
bending in various directions (Patent 20160255900 A1, 2014). Potential for
accelerometer sensors to be built into the helmet via the filaments to relay information
regarding components of forces to a coach or database for further research has been
proposed (Patent 20160255900 A1, 2014). VICIS also offers a custom fitting for each
helmet purchased so that the equipment is player specific (VICIS Co., 2016). While the
company does not suggest that the helmet will prevent concussions completely, it is
suggested that this equipment upgrade will provide more protection than current helmets
(VICIS Co., 2016).

2.

Side line test and return-to-play instructions
An underlying theme observed when evaluating research regarding concussion
reporting showed that athletes tend to report less symptoms and concussions than actually
experienced (Kroshus et al, 2014, Williams et al, 2015). 47.83% of division III hockey
players responded to having experienced concussive symptoms but did not report
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(Kroshus et al, 2014). One suggested reason for these omissions seems to stem from
player’s perception of whether the team’s personnel (i.e. coaches, medical staff, athletic
trainers) would be understanding to the presentation of concussion symptoms (Kroshus et
al, 2014). Another reason involves player’s perceptions on how taking time to recover
will negatively impact a position in the game or whether the coach will allow that player
back into the game (Kroshus et al, 2014, Williams et al, 2015). Education on how an
injured player who does not report would create unnecessary problems for the team if a
concussion went unreported was a proposed incentive for reporting concussions and
concussion symptoms to coaches and medical staff (Kroshus et al, 2014). Opening
dialogue between coaches and athletes on returning to play rules was suggested as an
option for alleviating players concerns regarding participation (Kroshus et al, 2014).
Overall, it was advised that player and coach education regarding concussions and
reporting should help with solving the concussion reporting problem (Kroshus et al,
2014).
Determination of an athlete’s recovery relies solely on the symptoms reported
and the length at which the symptoms were experienced (Williams et al, 2015). Williams
and associates determined from studies of high school and college level athletes that
recovery time for concussion symptoms were not the same between the two groups; high
schoolers reported recovering in 15 days versus the 6 days to recover for college athletes
(Williams et al, 2015). Cognitive recovery times varied slightly between the two groups
but were counted as similar findings, high school athletes within one week and college
athletes recovered within 5 days (Williams et al, 2015). Establishing a timeline for
concussion symptoms would be beneficial for players and coaches to deter further brain
injury during recovery (Williams et al, 2015). Williams et al suggested that variability
between concussive symptoms shows that players would benefit from individualized care
for recovery (Williams et al, 2015). However, since concussions can be difficult to
diagnose it was suggested that return-to-play guidelines should be followed for an
athlete’s recovery (Williams et al, 2015).
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Athletic trainers and medical staff for full-contact sports experience difficulties
in making a true concussive assessment when relying on players reported symptoms
(Williams et al, 2015). In some cases, medically trained staff may not be present due to
the level at which the sport is played (Leong et al, 2014). In light of the need for a quick
and uncomplicated concussion assessment tool, the King-Devick sideline test was created
(Leong et al, 2014). Concussions are determined by evaluating an athlete’s verbal and
visual response to reading numbers depicted on cards in a short amount of time (Leong et
al, 2014). Administration of this test to athletes revealed that concussed players
experienced an increase in time needed to complete the test compared to uninjured
players (Leong et al, 2014). King-Devick test results were compared to standard tests for
concussion evaluation (Leong et al, 2014). College football players suspected of
concussion were given all tests and the majority, with one player exception, could not
pass the tests administered (Leong et al, 2014). Early detection of concussion using the
King-Devick test was proposed as a quick method to successfully remove injured players
from a game (Leong et al, 2014).
3.

Putting an age limit on certain full-contact sports
It is difficult to determine how CTE development is propagated in younger
brains as a result of mTBI (Turner et al, 2015). McKee and associates propose that the
development of hyperphosphorylated tau and trauma are linked, but that many variables
are involved in CTE development including the age at which trauma has occurred
(McKee et al, 2015). While symptoms of CTE usually take years to present clinically,
confirmation of symptoms have been found in individuals as young as 14 years of age
(Mez et al, 2013). Individuals suffering from CTE related symptoms compose an older
demographic which could be attributed to poor equipment standards of the past (Omalu et
al, 2005). Explanation of risks associated with full-contact sports may help formulate a
range of ages individuals may choose to participate in these sports (Gandy et al, 2014.)
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4.

Avoidance of full-contact sports
Despite direct advisory from medical organizations and public opposition to
excessively violent full-contact sports, these athletic events continue to thrive (Gandy et
al, 2014). In current research, there has been a lack of a straight forward opinion on
whether full-contact sports propose significant enough risk to warrant the banning of fullcontact sports. Lipton et al recommended that soccer players may need to be limited in
the number of times that athletes head the ball due to a discovery between heading events
and structural changes to the temporo-occipital white matter of the brain (Lipton et al,
2013). McKee et al and Omalu et al both suggest that despite findings of CTE in the
brains of former athletes the evidence presented cannot formulate a direct relationship
between full-contact sports and CTE (McKee et al, 2013, Omalu et al, 2005).

VI.

Personal opinion
Establishing a solid link between head trauma and CTE is still in an early stage of
development. McKee and associates have built a strong model for disease development that will
effectively help identify tau formation in the brain when compared to imaging techniques.
However, the exact cause of CTE is most likely multifactorial in nature. Biomarker and scanning
techniques will be critical tools for living patients suspected of having CTE, and how the disease
develops over time. Research from this review revealed that there are multiple areas where
questions could arise and how these topics relate to disease development. Imaging techniques will
provide valuable information on many of the areas where questions remain. My personal opinion
regarding concussions and long term risks of potential CTE development is that there must be a
link between mTBI and disease development within the brain. Time and further research will
develop better answers regarding the full picture of disease causation and development. However,
health risks arising from head trauma does not seem to be beyond the scope for causing serious
problems in the future.
1.

Questions for further research
a. What areas should receive further research?
Topics where data are unclear regarding relationships varies from the
activity that was responsible for initiation of the disease to protein processes and
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genetics. Age and the role it plays in disease development is one area of interest
due to a lack of data regarding biological processes in the aged. Questions
regarding the differences between the effects of concussive damage in younger
and older individuals are especially important. If it was established that head
trauma at an earlier age effects proper brain development in children and
adolescents, there would need to be changes made to age limits for full-contact
sports.
Gender and the role that hormones play in disease development are also
warranted. In this review it was clear that the potential for females to be better
protected by hormonal processes could explain why the number of reports of
CTE type symptoms are predominantly in males. However, it should be noted
that female brains and data regarding female full-contact athletes is sparse if
available at all.
Certain predisposing genotypes such as the APOE phenotypes and how
that could lead to CTE development is also an area where further research
should continue. One glaring factor that makes establishing a cause and effect
relationship difficult is the variability between patients. In general, human
beings do not all function the same way and the addition of the factors above
add to the difficulty of establishing clear data. However, further research in
these areas will not only benefit studies regarding CTE but will also generate
pertinent data for the neurodegenerative disease research community, as well as
many others.
Research should continue to spread to areas beyond a laboratory
setting. Data are missing from areas regarding concussion potential from noncontact sports and every type of full-contact sport that could be involved. Types
of injuries should be evaluated on which impacts could present more harm than
others and what forces are needed to generate the most damage. Sports
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equipment should also undergo serious stress testing to determine where faults
may lie and how those defects can be prevented.
b.

Should full-contact sports be banned?
Full-contact sports are a large part of American culture. Michigan
residents in particular have a strong devotion to football and ice-hockey.
Increased news regarding athlete suicides and the expressed concerns of
surviving retired players are startling. Clearly there is a need for answer to this
health concern. Promotion of violence in full-contact sports has significantly
skewed what my perceived goals of sports used to entail. Younger individuals
are being pushed into acting with excessive violence against other young
athletes for the sake of winning a trophy, or a title. I do not believe that this
makes any sort of sense, and I worry for those that believe sacrificing the brains
of athletes is worth attaining some award. Placing the blame on who is directly
responsible for allowing this to happen is difficult to determine, whether it was
the fault of coaches or larger groups like the NFL requires some clarity. There
are a variety of other sports that athletes could continue to thrive in where risks
of concussion are virtually nonexistent. It would be in the best interest of
athletes to investigate these other potential sports options because the overall
risk of CTE development is not worth developing this disease.

2.

Pros and cons of current research
a. Low coverage for all age ranges and sexes
Age as a factor in CTE development was very imbalanced when I
observed the current research. Many of the research participants were middleaged or older. In certain cases, older (i.e. 65+) individuals presented with
comorbid diseases making it difficult to identify which disease was involved
with a patient’s symptoms. If the data were not clear, then removing that
information was necessary. Removal of confounding data decreases the sample
size and detracts from the value of the study. Biomarker use in surviving
individuals will help in distinguishing between diseases that are developing.
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Data regarding potential CTE development in females is extremely
low. Since football has gained the most attention for potential CTE risk it is not
surprising that female athletes have been over looked during research. It would
be of benefit to investigate whether CTE develops in the brains of female
athletes in the same manner as it does in males. One of the reasons I chose to
cover estrogen as a protective hormone was due to the lack of data. If hormones
play a larger role in CTE research, this could lead to further breakthroughs in
finding cures to prevent the spread of this disease. While selection bias has been
a concern throughout the study of CTE adding female full-contact sport athletes
to the study populations would alleviate a part of that problem.
b.

Sample sizes and types of studies
Sample sizes tended to be rather small in the earlier years of CTE
research but have started to grow as athletes learn more about the disease. Fullcontact sport athletes have a desire to know what might happen in the future and
how to prepare if diagnosed with CTE. In general, larger and more diverse
sample sizes should be included in CTE research.
One aspect to consider when conducting CTE research is including
anonymity. Certain groups may feel more secure if the data does not easily
distinguish specific individuals from others. Anonymous responders may also
have pertinent information regarding areas of sports medicine that need further
investigation. It was a benefit in the study conducted by Kroshus et al and will
most likely help improve ethical standards for medical and sport related staff.
A consistent theme observed in my research was the need for
longitudinal studies. Research observed relied heavily on cross-sectional studies,
qualitative studies and meta-analysis to establish connections between CTE and
head trauma. Qualitative studies have a slight benefit by providing descriptions
of sports where concussions are of a greater risk. However, the impact data
required to cause a concussion seems far more important in understanding
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disease development. I believe that use of imaging and biomarkers will be
beneficial for studies that are attempting to track the disease properly for
longitudinal data to be collected.
VII.

Conclusion
CTE research is ongoing and is attempting to answer many of the questions that have arose during

studies, or that appear to be related to the disease. The findings of McKee et al have established a
significant model for use in imaging techniques for comparing images to autopsy reports (Barrio et al,
2015, McKee et al, 2013). Research in a variety of associated sciences should continue to collaborate
as studies regarding CTE development continue (Gandy et al, 2014).
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